Contact
searchSearch
HMP Global
Login

Business

Business
Details business of pathways, including, but not limited to financing and payment incentives, HEOR, predictable cost of care (PCOC), and cost modeling.

From the Field
Shining a Light on Payer Management in Medical-Benefit Oncology: A Call for Action to Prioritize Patient Care
04/18/2026
Lucio Gordan, MD; Kiana Mehring, MBA, PPMC; David T. Wenk, MD; Josh Eaves; Ryan Ciarrocchi
This study reveals how increasing payer control over oncology treatments is driving delays and administrative burden, undermining evidence-based, physician-led care and timely patient access.
This study reveals how increasing payer control over oncology treatments is driving delays and administrative burden, undermining evidence-based, physician-led care and timely patient access.
This study reveals how...
04/18/2026
Journal of Clinical Pathways
Transformative Business Trends
Navigating the Turns: Steering Health Benefits Through Economic and Clinical Transitions
04/16/2026
F. Randy Vogenberg, PhD, FASHP
As double-digit cost increases collide with economic uncertainty, employers are turning to data-driven clinical pathways to better control spending, improve outcomes, and shape more targeted health benefits for 2027.
As double-digit cost increases collide with economic uncertainty, employers are turning to data-driven clinical pathways to better control spending, improve outcomes, and shape more targeted health benefits for 2027.
As double-digit cost increases...
04/16/2026
Journal of Clinical Pathways
ONLINE EXCLUSIVES
Episode 5: PBMs, Part D, and Pathways—Who Really Controls Oncology Access?
04/08/2026
Gordon Kuntz; Bryan Loy, MD, MBA
In this episode of The Pathways Guys Podcast, our hosts cover Medicare Part D formularies in oncology, explaining how pharmacy benefit managers design drug coverage and how this impacts oncology market access, reimbursement, and patient care.
In this episode of The Pathways Guys Podcast, our hosts cover Medicare Part D formularies in oncology, explaining how pharmacy benefit managers design drug coverage and how this impacts oncology market access, reimbursement, and patient care.
In this episode of The Pathways...
04/08/2026
Journal of Clinical Pathways
ONLINE EXCLUSIVES
Why Payers Have Pathways—and What “Quality Care” Really Means
02/10/2026
Gordon Kuntz; Bryan Loy, MD, MBA
This Online Exclusive features the debut episode of The Pathways Guys podcast, a series exploring the real-world impact of clinical pathways on oncology policy, payment, and practice.
This Online Exclusive features the debut episode of The Pathways Guys podcast, a series exploring the real-world impact of clinical pathways on oncology policy, payment, and practice.
This Online Exclusive features...
02/10/2026
Journal of Clinical Pathways
Transformative Business Trends
Policy Update Impacts on Employer Health Plans in 2026
02/10/2026
F. Randy Vogenberg, PhD, FASHP
This column discusses how shifting federal policy, employer health plan economics, and rising drug costs in 2026 will reshape business decisions that directly influence oncology access, affordability, and clinical pathway sustainability.
This column discusses how shifting federal policy, employer health plan economics, and rising drug costs in 2026 will reshape business decisions that directly influence oncology access, affordability, and clinical pathway sustainability.
This column discusses how...
02/10/2026
Journal of Clinical Pathways
CPC+CBEx Conference Highlights
The View From the Stage: How AI, Data, and Pharmacist Leadership Drove Discussion at CPC+CBEx 2025
12/15/2025
Gordon Kuntz
Gordon Kuntz provides a recap of the 9th annual Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), highlighting important themes and notable sessions.
Gordon Kuntz provides a recap of the 9th annual Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx), highlighting important themes and notable sessions.
Gordon Kuntz provides a recap of...
12/15/2025
Journal of Clinical Pathways
Transformative Business Trends
Trends and Issues for US Employer Insurance: Forecasting 2026-2030 Health Care Coverage
12/10/2025
F. Randy Vogenberg, PhD, FASHP
In this column, F. Randy Vogenberg, PhD, FASHP, reviews health care stakeholders’ final pri­orities for 2025 and the transition to a more complex business­-driven shift in risk mitigation for 2026 health care coverage.
In this column, F. Randy Vogenberg, PhD, FASHP, reviews health care stakeholders’ final pri­orities for 2025 and the transition to a more complex business­-driven shift in risk mitigation for 2026 health care coverage.
In this column, F. Randy...
12/10/2025
Journal of Clinical Pathways
Transformative Employer Trends
Employers and Manufacturers: A Call to Action to Co-Lead the Future of Health Care
10/15/2025
F. Randy Vogenberg, PhD, FASHP
As unprecedented medical and technological advances outpace existing care and reimbursement models, employers and manufacturers must collaborate through data-driven, trust-based frameworks to ensure equitable access to care.
As unprecedented medical and technological advances outpace existing care and reimbursement models, employers and manufacturers must collaborate through data-driven, trust-based frameworks to ensure equitable access to care.
As unprecedented medical and...
10/15/2025
Journal of Clinical Pathways
COA Viewpoint
Will CMS Fix the IRA for Community Oncology Before It’s Too Late?
10/15/2025
Nicolas Ferreyros
Congress’s effort to lower drug prices through the Inflation Reduction Act may have unintended—and potentially devastating—consequences for community oncology practices, threatening access and affordability for the majority of Americans...
Congress’s effort to lower drug prices through the Inflation Reduction Act may have unintended—and potentially devastating—consequences for community oncology practices, threatening access and affordability for the majority of Americans...
Congress’s effort to lower drug...
10/15/2025
Journal of Clinical Pathways
Transformative Business Trends
Employer-Driven Health Care: Opportunities for Change
10/15/2025
F. Randy Vogenberg, PhD, FASHP
As government reforms and market pressures reshape the health insurance landscape, this column explores how employers, manufacturers, and policymakers must realign their strategies to bridge transparency gaps, manage rising costs, and sustain...
As government reforms and market pressures reshape the health insurance landscape, this column explores how employers, manufacturers, and policymakers must realign their strategies to bridge transparency gaps, manage rising costs, and sustain...
As government reforms and market...
10/15/2025
Journal of Clinical Pathways

Current Issue

April 2026
Volume 12
Issue 2
Current Issue
Issue Archive

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use